{"version":"1.0","type":"link","title":"Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8 Effector T‑Cell Function for Synergistic Cancer Immunotherapy.","author_name":"Ao K 외","author_url":"https://prs-insight.online/author/Ao%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/170339","thumbnail_width":1200,"thumbnail_height":630}